Skip to content
DataLookout
Menu

BCB RIVNCT04104529

Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 2 years 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 15 versions: 11 with changes below, 4 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Study completion pushed from Oct 2029 to Oct 2036
  2. Notable Primary and study completion pushed from Oct 2026 to Oct 2029 Show 4 more changesShow less
    • Eligibility criteria expanded, about 21 words
    • Study description expanded, about 38 words
    • Site details revised at 1 of 4 sites
    • Publications: 25 to 29
  3. Minor Publications: 24 to 25v12
  4. Minor Site details revised at 1 of 4 sitesv9
  5. Minor Study sites: 3 to 4v8
Show 5 earlier versionsHide 5 earlier versions
  1. Minor Site details revised at 1 of 3 sitesv7
  2. Minor Publications: 2 to 24v6
  3. Notable Primary and study completion dates: Oct 2024 to Oct 2026v5 Show 4 more changesShow less
    • Eligibility criteria shortened, about 3 words
    • Study sites: 1 to 3
    • Interventions: Biological collection (Other) to Biological collection (Other), tumor collection (Other)
    • Study description expanded, about 124 words
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2019 to Oct 28, 2019
    v3
  5. Minor Study description shortened, about 5 wordsv2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of patients who gave their consent to participate in the study
Timeframe: Until the study completion: 5 years

Arms and interventions

Biological collectionExperimental

Biological collection For all the patients include in the study : samples of blood samples collected before and during treatment. In parallel to this biological collection, standardized clinical data will be entered into a database Ancillary study : For metastatic thyroïd cancer and neuroendocrine tumor : anapath blocks of the initial diagnosis will be archived and dosimetric data will be collected for the cycle 1 For neuroendocrine tumor : blood sample additionnal will be realized at the cycle 1 (pre and post treatment)

Other: Biological collection, tumor collection

Sites

4 sites in 1 country